BACKGROUND: Metalloproteinase-9 (MMP-9) is a type IV collagenase found at elevated levels in chronic wounds. As wounds heal, MMP-9 diminishes. In this study, we investigated whether MMP-9 directly contributes to chronic wound pathogenesis. METHODS: Recombinant proMMP-9 was prepared using immortalized keratinocytes transduced by a lentivirus. ProMMP-9 was purified from cell culture media and activated using 4-aminophenylmercuric acetate. Active MMP-9 was then suspended in xanthan gum to a concentration paralleling that found in human chronic wounds. Two parallel 6-mm punch biopsies were made on the backs of C57BL mice. Wounds were treated daily with MMP-9 or vehicle. Wound areas were measured and tissues examined by densitometry, real-time RT-PCR, histology, and immunohistochemistry at days 7, 10, and 12. RESULTS: Exogenous MMP-9, at the level found within chronic wounds, delayed wound healing in this animal model. By 7 days, wounds in the MMP-9-injected group were 12% larger than control wounds (P = .008). By day 12, wounds in the MMP-9-injected group were 25% larger than those of the control group (P = .03). Histologic examination shows that high levels of active MMP-9-impaired epithelial migrating tongues (P = .0008). Moreover, consistent with elevated MMP-9, the collagen IV in the leading edge of the epithelial tongue was diminished. CONCLUSION: MMP-9 appears to directly delay wound healing. Our data suggests that this may occur through interference with re-epithelialization. We propose that MMP-9 interferes with the basement membrane protein structure, which in turn impedes keratinocyte migration, attachment, and the reestablishment of the epidermis. Copyright 2010 Mosby, Inc. All rights reserved.
BACKGROUND: Metalloproteinase-9 (MMP-9) is a type IV collagenase found at elevated levels in chronic wounds. As wounds heal, MMP-9 diminishes. In this study, we investigated whether MMP-9 directly contributes to chronic wound pathogenesis. METHODS: Recombinant proMMP-9 was prepared using immortalized keratinocytes transduced by a lentivirus. ProMMP-9 was purified from cell culture media and activated using 4-aminophenylmercuric acetate. Active MMP-9 was then suspended in xanthan gum to a concentration paralleling that found in human chronic wounds. Two parallel 6-mm punch biopsies were made on the backs of C57BL mice. Wounds were treated daily with MMP-9 or vehicle. Wound areas were measured and tissues examined by densitometry, real-time RT-PCR, histology, and immunohistochemistry at days 7, 10, and 12. RESULTS: Exogenous MMP-9, at the level found within chronic wounds, delayed wound healing in this animal model. By 7 days, wounds in the MMP-9-injected group were 12% larger than control wounds (P = .008). By day 12, wounds in the MMP-9-injected group were 25% larger than those of the control group (P = .03). Histologic examination shows that high levels of active MMP-9-impaired epithelial migrating tongues (P = .0008). Moreover, consistent with elevated MMP-9, the collagen IV in the leading edge of the epithelial tongue was diminished. CONCLUSION:MMP-9 appears to directly delay wound healing. Our data suggests that this may occur through interference with re-epithelialization. We propose that MMP-9 interferes with the basement membrane protein structure, which in turn impedes keratinocyte migration, attachment, and the reestablishment of the epidermis. Copyright 2010 Mosby, Inc. All rights reserved.
Authors: N J Trengove; M C Stacey; S MacAuley; N Bennett; J Gibson; F Burslem; G Murphy; G Schultz Journal: Wound Repair Regen Date: 1999 Nov-Dec Impact factor: 3.617
Authors: Merry L Lindsey; G Patricia Escobar; Lawrence W Dobrucki; Danielle K Goshorn; Shenikqua Bouges; Joseph T Mingoia; David M McClister; Haili Su; Joseph Gannon; Catherine MacGillivray; Richard T Lee; Albert J Sinusas; Francis G Spinale Journal: Am J Physiol Heart Circ Physiol Date: 2005-08-26 Impact factor: 4.733
Authors: Julie T Daniels; Gerd Geerling; Robert A Alexander; Gillian Murphy; Peng T Khaw; Ulpu Saarialho-Kere Journal: Exp Eye Res Date: 2003-12 Impact factor: 3.467
Authors: David R Colnot; Jan C Roos; Remco de Bree; Abraham J Wilhelm; J Alain Kummer; Gertraud Hanft; Karl-Heinz Heider; Gerd Stehle; Gordon B Snow; Guus A M S van Dongen Journal: Cancer Immunol Immunother Date: 2003-09 Impact factor: 6.968
Authors: Fang Bian; Flavia S A Pelegrino; Stephen C Pflugfelder; Eugene A Volpe; De-Quan Li; Cintia S de Paiva Journal: Invest Ophthalmol Vis Sci Date: 2015-07 Impact factor: 4.799